TrialAntimicrobial agents and chemotherapy2015

Hepatitis C virus genotype 4 resistance and subtype demographic characterization of patients treated with ombitasvir plus paritaprevir/ritonavir.

Gretja Schnell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.